The results showed that the TBC1D3 expression was respectively higher in KIRC, KIRP (kidney renal papillary cell carcinoma), LIHC (liver hepatocellular), LUAD (lung adenocarcinoma), LUSC (lung squamous cell carcinoma), and THCA (thyroid carcinoma). This evidence concerns the gene TBC1D3 and lung adenocarcinoma.